Damián, Alejandra
Núñez-Moreno, Gonzalo
Jubin, Claire
Tamayo, Alejandra
de Alba, Marta Rodríguez
Villaverde, Cristina
Fund, Cédric
Delépine, Marc
Leduc, Aurélie
Deleuze, Jean François
Mínguez, Pablo
Ayuso, Carmen
Corton, Marta
Funding for this research was provided by:
Instituto de Salud Carlos III (FI18/00123, PI17/00164, CPII21/00015, PI17/00164)
Comunidad de Madrid (PEJ-2020-AI/BMD-18610, PEJ-2020-AI/BMD-18610)
Centro de Investigación en Red en Enfermedades Raras (06/07/0036)
European Advanced Infrastructure for Innovative Genomics (PID10291)
Fundación ONCE
Fundación Mutua Madrileña
Federación Española de Enfermedades Raras
Article History
Received: 3 March 2023
Accepted: 8 May 2023
First Online: 2 June 2023
Declarations
:
: The study was approved by the Ethics Research Committee of the University Hospital Fundación Jimenez Díaz (PICO15_18_FJD and PIC059-21) and complied with the guidelines of the Declaration of Helsinki and further reviews. All participants or their legal guardians gave written informed consent to participate and publish genetic and clinical data.
: The authors declare no competing interests.